Efe, S. Et Al. 2023. The use of furosemide during Intravenous Immunoglobulin therapy should not always be considered contraindicated. MEDICINE IN DRUG DISCOVERY , vol.21 , 100171.

Efe, S., Demircan, F., Uçan, A., & İnal, V., (2023). The use of furosemide during Intravenous Immunoglobulin therapy should not always be considered contraindicated. MEDICINE IN DRUG DISCOVERY , vol.21, 100171.

Efe, SERDAR Et Al. "The use of furosemide during Intravenous Immunoglobulin therapy should not always be considered contraindicated," MEDICINE IN DRUG DISCOVERY , vol.21, 100171, 2023

Efe, SERDAR Et Al. "The use of furosemide during Intravenous Immunoglobulin therapy should not always be considered contraindicated." MEDICINE IN DRUG DISCOVERY , vol.21, pp.100171, 2023

Efe, S. Et Al. (2023) . "The use of furosemide during Intravenous Immunoglobulin therapy should not always be considered contraindicated." MEDICINE IN DRUG DISCOVERY , vol.21, p.100171.

@article{article, author={SERDAR EFE Et Al. }, title={The use of furosemide during Intravenous Immunoglobulin therapy should not always be considered contraindicated}, journal={MEDICINE IN DRUG DISCOVERY}, year=2023, pages={100171} }